Professor Shabir A. MadhiA South African scientist whose research has shaped vaccine policy and protected millions of children worldwide has been recognised with one of the most prestigious honours in infectious disease research, highlighting Africa's growing role in advancing global health innovation.
Professor Shabir A. Madhi, a leading vaccinologist and public health expert at the University of the Witwatersrand (Wits University), has been named the recipient of the 2026 Maxwell Finland Award for Scientific Achievement by the National Foundation for Infectious Diseases (NFID) in the United States.
The award recognises researchers whose work has had a lasting impact on the prevention, treatment, and control of infectious diseases. Madhi joins a distinguished group of international scientists whose discoveries have transformed public health around the world.
For more than two decades, Madhi has led research that has generated critical evidence for the use of vaccines against some of the world's deadliest diseases. Much of this work has been conducted in Africa, helping ensure that global vaccine policies are informed by data from the populations most affected by infectious diseases.
His research on pneumococcal conjugate vaccines, conducted through a landmark study involving nearly 40,000 South African children, provided key evidence supporting the introduction of life-saving vaccines that are now estimated to have prevented hundreds of thousands of child deaths globally. His work also contributed to international recommendations on rotavirus vaccination, helping expand access to protection against severe diarrhoeal disease in low- and middle-income countries.
Madhi has also been at the forefront of maternal immunisation research. His studies demonstrated that vaccinating pregnant women against influenza can protect both mothers and newborns, paving the way for further research into maternal vaccines against respiratory syncytial virus (RSV) and Group B Streptococcus.
During the COVID-19 pandemic, Madhi once again helped place Africa at the centre of global scientific efforts by leading the continent's first SARS-CoV-2 vaccine trials. The studies generated crucial evidence that informed vaccine deployment strategies and pandemic response efforts worldwide.
Beyond his scientific achievements, Madhi has played a significant role in building Africa's vaccine research capacity by mentoring young scientists and strengthening clinical research networks across the continent.
Announcing the award, global health leaders praised Madhi's contributions to science and public health, noting that his work has influenced vaccine policy, expanded access to immunisation, and improved disease prevention efforts across multiple generations.
Madhi will receive the Maxwell Finland Award at the NFID Awards Gala in Washington, DC, on 20 October 2026, marking another milestone for African-led research on the global stage.
Photo courtesy: University of Wits
Article by Jed Mwangi
Comment